Nouvelles

E.g., 06/25/2018
E.g., 06/25/2018
An article by FiercePharma
August 9, 2016 - German diabetes specialist Emperra has launched the first wireless insulin pen that transfers data to a patient’s blood glucose diary via Bluetooth. The CE-marked device is launching in Germany with an eye toward an FDA approval...
An article by FiercePharma
August 9, 2016 - Florida’s HedgePath Pharmaceuticals heralded a positive midstage study for its oral capsules designed to treat a complication associated with basal cell carcinoma. The oral regimen demonstrated effectiveness in reducing tumor size...
An article by FiercePharma
August 4, 2016 - Scientists have been developing vaccines that could stop disease outbreaks more quickly. Now, researchers at the Massachusetts Institute of Technology are moving ahead with easy-to-make experimental jabs that can ward off a...
An article by FierceBiotech
August 3, 2016 - The companies behind biologic drugs argue that the branded drugs and their generic versions, dubbed biosimilars, are not interchangeable. But a new study suggests otherwise, at least for a class of biologics called TNF-α...
An article by FierceHealthcare
August 3, 2016 - An interactive broadband mapping tool created by the Federal Communications Commission will help ensure a lack of connectivity is no longer “a super-determinant of health,” according to FCC Commissioner Mignon L. Clyburn. The tool...
An article by FiercePharma
August 3, 2016 - As the number of Zika cases continues to rise in the U.S., researchers at the National Institutes of Health are launching a clinical trial of a vaccine meant to ward off the virus and prevent serious complications in infants. The...
An article by FiercePharma
August 3, 2016 - Sanofi ($SNY) provided insight into the logistics hurdles faced by vaccine makers in China after distribution and sales rule changes made in response to illegal vaccine sales. The changes implemented recently--which were rooted in...
An article by FiercePharma
August 2, 2016 - Pfizer’s ($PFE) Prevnar 13 sales were down in Q2 after management laid out low projections for the vaccine in 2016. But things could pick up again for Prevnar thanks to a new FDA approval. Sales of Prevnar 13 fell 16% in Q2 2016...
An article by FierceBiotech
August 1, 2016 - GlaxoSmithKline ($GSK) has announced a major new joint venture with Verily--once Google Life Sciences--as the two join forces with the hope of creating the first generation of bioelectronic medicines for chronic diseases. GSK has...
An article by The New York Times
July 30, 2016 - Some of the most promising advances in cancer research in recent years involve treatments known as immunotherapy. These advances are spurring billions of dollars in investment by drug companies, and are leading to hundreds of...
Un artículo por El País
July 29, 2016 - El Estado de Florida confirmó este viernes los primeros cuatro casos de transmisión del virus del Zika por picaduras de mosquito autóctono. El gobernador Rick Scott reveló que a pesar de que las autoridades aún no han detectado...
An article by FiercePharma
July 29, 2016 - Having spent two decades and $1.5 billion developing its first-of-a-kind dengue vaccine, Sanofi is sure to be unhappy to report that Dengvaxia’s launch has been slower than anticipated. In second quarter results issued Friday, the...
An article by FierceBiotech
July 29, 2016 - Pfizer ($PFE) has secured an exclusive option to acquire Western Oncolytics’ WO-12. The deal gives Pfizer a chance to pick up the oncolytic vaccinia virus once it has completed Phase I, something the Big Pharma will work to achieve...
Un articulo por la OPS/OMS
July 27, 2016 - En las Américas, las hepatitis virales causan más de 125.000 muertes al año y la gran mayoría de estos fallecimientos es por hepatitis B y C. El 90% de las personas infectadas con hepatitis C pueden curarse si reciben un...
An article by FiercePharma
July 27, 2016 - After making a big bet on the field, GlaxoSmithKline ($GSK) continues to post gains in vaccines. In second-quarter results released Wednesday, the British pharma reported that its vax group notched the highest growth of the company...
An article by FierceBiotech
July 27, 2016 - Researchers at MIT have published a paper about an adhesive hydrogel patch that could be used in the treatment of colorectal tumors after surgery.   Surgery is often the first treatment used in cases of colorectal cancer. However,...
An article by FiercePharma
July 26, 2016 - One month after luring influential biotech entrepreneur Jörn Aldag to serve as its CEO, Vienna, Austria’s Hookipa Biotech is taking a cytomegalovirus vaccine candidate into a first-in-human trial. Dubbed HB-101, the vaccine will...
An Editorial by WHO
July 26, 2016 - The range of abnormalities seen and the likely causal relationship with Zika virus infection suggest the presence of a new congenital syndrome. The Zika virus public health emergency is distinct because of its long-term health...
An article by Le Monde
July 25, 2016 -   C’est le premier cas recensé en Europe: lundi 25 juillet, les responsables de l’hôpital de Barcelone ont annoncé la naissance d’un bébé atteint d’une microcéphalie (développement insuffisant du crâne et du cerveau) due au virus...
An article by FiercePharma
July 25, 2016 - While much of the world has moved on to the latest headline-grabbing outbreak in Zika, Merck continues to press on with its Ebola vaccine candidate. On Monday, the New Jersey pharma announced its rVSV-ZEBOV has won the FDA’s...

Pages